EMEA-001902-PIP01-15-M04
Key facts
| Invented name |
Ondexxya
|
| Active substance |
andexanet alfa
|
| Therapeutic area |
Other
|
| Decision number |
P/0349/2020
|
| PIP number |
EMEA-001902-PIP01-15-M04
|
| Pharmaceutical form(s) |
Powder for solution for infusion
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
AstraZeneca AB
E-mail: paediatrics@astrazeneca.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|